Europe: new prevention solutions for swine farming
2024/03/07 - Products
One year after the launch of Suigen Rota Coli, our teams in France and Germany are now offering a second vaccine for swine, Suigen APP 2,9,11. This new vaccine complements our solutions for the prevention of major swine diseases, helping farmers to better control the health of their farms.
Virbac to take a leading position in Japan through the acquisition of Sasaeah
2024/03/06 - Financial public releases
Virbac announces that it has signed a definitive agreement with ORIX Corporation for the acquisition of its animal health subsidiary Sasaeah for an enterprise value of approximately €280 million.
Virbac: Olivier Charmeil co-opted by the board of directors
2024/01/24 - Career
Virbac announces the appointment of Olivier Charmeil as a new member of the board of directors with effect from December 21, 2023. He replaces Olivier Bohuon, permanent representative of OJB Conseil, within the board of directors and the appointments and compensation committee.
Virbac shampoos for dogs and cats get a makeover!
2024/01/23 - Products
Our range of dermatological (AKI) and hygiene (Allerderm) shampoos has been redesigned to limit ecological impact and simplify use for pet owners. The new packaging is now made from recycled plastic, while the innovative formulations, which have been constantly improved over the last few decades, remain unchanged.
2023 fourth quarter consolidated sales
2024/01/17 - Financial public releases
Happy New Year 2024!
2024/01/08 - Press
Discover the video of Sébastien Huron's wishes to all Virbac teams worldwide.
Dog and cat nutrition: the beginnings of a new approach in China
2023/12/14 - Products
Available in five major Chinese cities since last October, our Veterinary HPM® physiological foods are the only ones in the country to be distributed exclusively in veterinary clinics. This is a novel approach in the region, in line with our medical and scientific approach to animal nutrition.
Pets: a step towards more reasoned pest control
2023/11/23 - Products
Because we are all part of the same ecosystem, parasite control is a necessity which must be carried out while preserving the delicate balance between the health of animals, humans and their environment. With “Let's do it smart”, we provide veterinarians with the tools they need to tailor the solution to the animal's specific needs, thus contributing to a more reasoned use of parasiticides.
France: Virbac certified as an Authorized Economic Operator
2023/11/10 - Press
At the end of October, the French Customs Department awarded our Group the status of Authorized Economic Operator (AEO): a European customs seal of approval, recognized on the international scene.
Virbac Uruguay celebrates its 10 years and builds a new factory
2023/11/03 - Press
On October 17, Virbac Uruguay celebrated 10 years of commitment to animal health in Montevideo. On this occasion, the foundation stone for our new viral antigen plant was laid in the presence of the President of the Republic of Uruguay.
Virbac acquired a majority stake in Globion, a leading Indian poultry vaccines specialist
2023/11/02 - Financial public releases
On November 1, we successfully finalized the acquisition of a majority stake in Globion. This transaction will bolster our position of animal health leader in India by extending Virbac India’s existing poultry portfolio to the growing segment of avian vaccines.
2023 third quarter consolidated sales
2023/10/23 - Financial public releases
USA: Virbac innovates for the treatment of Giardia duodenalis infections in dogs
2023/10/18 - Products
On October 11, 2023, the U.S. Food and drug administration (FDA) approved our solution for the treatment of Giardia duodenalis infections in dogs.
Dog oral health: an effective solution against plaque and tartar
2023/10/13 - Products
A study published in September 2023 has scientifically demonstrated that Vet Aquadent® FR3SH™ is an effective option to help maintain dogs' oral health after professional dental cleaning.
Virbac will enter the fast-growing poultry vaccines segment in India
2023/10/09 - Financial public releases
Virbac announces the signing of an agreement to acquire Globion, a leading Indian poultry vaccines specialist. This transaction will bolster our position of animal health market leader in India by extending Virbac India’s existing poultry portfolio to the growing segment of avian vaccines.
2023 half year results
2023/09/28 - Financial public releases
Nutrition: a new approach for aging cats
2023/09/07 - Products
In France and around the world, the medicalization of cats continues to progress, helping to increase their life expectancy. Two major pathologies affect these aging cats: chronic kidney disease and osteoarthritis. Specially adapted nutrition can help. That's why we're launching VETERINARY HPM® Kidney & Joint in Europe in September. This new nutrition program enables the combined and gradual management of chronic kidney disease and osteoarthritis, thus improving the animal's quality of life.
2023 half-year results: publication postponed to end of September
2023/08/22 - Financial public releases
At the end of August, with our priority systems fully restored and functional following the June cyberattack, we will be able to publish our mid-year results on September 28 with a two-week delay.
Celebrating 30 years in New Zealand!
2023/07/21 - Press
In June 2023, Virbac New Zealand celebrated 30 years of its commitment to animal health in Aotearoa New Zealand. All employees gathered together to mark this amazing achievement and look back on these past three decades.
2023 second quarter consolidated sales
2023/07/18 - Financial public releases
Virbac Japan celebrates 30 years!
2023/07/07 - Press
Last May, Virbac Japan employees gathered to celebrate the subsidiary's 30 years of commitment to animal health.
Virbac reassesses its 2023 growth and Adjusted EBIT1 forecast
2023/07/03 - Financial public releases
André Mathieu appointed director of Global Industrial Operations, Supply Chain and Sourcing
2023/07/03 - Career
From July 2023, André Mathieu, appointed director of Virbac's Global Industrial operations, Supply chain & Sourcing since January 2, 2023, will join Virbac’s Group executive committee.
Cyber attack on several sites
2023/06/27 - Press
The Virbac Group was the target of a cyber attack on several of its sites worldwide during the night of June 19-20.
Virbac reverses canine acute otitis externa treatment habits
2023/06/15 - Products
Otitis externa is one of the main reasons why dogs visit the vet. Highly uncomfortable and painful for the animal, their treatment has until now involved the use of antibiotics in most of the cases. Starting this June, our teams are changing the way the disease is managed, by offering a Europe-wide antimicrobial-free solution, recommended as a first-line treatment in acute canine otitis externa where microbial overgrowth.
Virbac: Manuela Rodriguez appointed CSR (Corporate social responsibility) director
2023/05/31 - Career
Virbac announces the appointment of Manuela Rodriguez as CSR director, effective April 3, 2023. Her main mission will be to develop and manage the Group's CSR strategy.
Virbac Spain: 40 years of commitment
2023/05/15 - Press
Founded in 1983, Virbac Spain, one of the Group's oldest subsidiaries, celebrated 40 years of commitment to animal health on 11 May.
DailyDerma: a new routine for long-lasting relief for atopic dogs
2023/05/12 - Products
Atopic dermatitis is an inflammatory skin disease that affects 10% of dogs1. Very disabling for the animal, it is also complex to diagnose and treat. To improve its management, our teams have developed DailyDerma: an innovative programme that brings together veterinarians and owners for better long-term management of the disease.